Background: Diabetic cardiomyopathy (DCM) is a major cause of diabetes-related morbidity
Introduction
Cardiomyopathies are diseases of the heart muscle that are associated with cardiac dysfunction and heart failure and thus they represent a major health AMPK was proved to be also activated by oxidative stress (8) . On the other hand, dysfunctional AMPK activity is related to the decrease of antioxidant gene expression and the increase of oxidants' production resulting in oxidative stress development (9) . Oxidative stress has been linked to the onset of diabetes (10 Blood and heart Collection: The day of sacrifice, rats were weighed then euthanized by deep anesthesia with 100 mg/kg pentobarbital. The chest wall was opened using scissors to expose the heart, which was then removed and immediately weighed for calculating the heart/body weight ratio. The heart tissues were divided into two halves. One half was then stored at -80°C until assay and the other one was fixed in 10% formalin for histological examination. The blood was collected from the aorta with EDTA-treated syringe needles, and immediately mixed with 3.2% sodium citrate at a ratio of 9:1 (blood volume/citrate volume). It was then centrifuged at 1,500 ×g for 15 minutes to separate the plasma that was frozen in aliquots at -80°C until assay.
AMPK activity:
The heart tissue samples were homogenized, one half in a buffer containing 30mM tris-Hcl, 150Mm Nacl, 1mM EDTA, 1mM
EGTA, 1%Triton X-100and 0.5ML/ml of protease inhibitor cocktail F (Bio Basic Inc, Canada). The homogenate was then centrifuged at 100,000 ×g The protein content of the supernatants was determined using Lowry's method (21 (C+ALAG, C+MelG) did not affect the heart size when compared to NG (Table 1) .
Effects of melatonin and ALA on CK and LDH
The levels of LDH, and CK were significantly increased in diabetic untreated rats compared with the normal control rats (p≤0.05). However, melatonin and ALA treatment markedly reduced the levels of CK and LDH. There was no difference in the effect of melatonin and ALA on cardiac enzymes in diabetic rats (Table 1) .
Effects of Melatonin and ALA on AMPK level
Western blot analysis showed that cardiac AMPK 155.0±2.6 RGB/mg protein respectively) with no significant difference between the two latter groups (Table 1) .
A significant negative correlation was found between AMPK and cardiac enzymes in all experimental groups. (Figure 1 
Effects of Melatonin and ALA on Lipid profile
Lipid profile was impaired in streptozotocindiabetic rats. The treatment with melatonin and ALA caused a significant reduction of the cholesterol, TG and LDL levels in diabetic rats.
On the other hand, HDL was significantly increased compared to diabetic untreated group (DG) ( Table 2 ).
Effects of Melatonin and ALA on FBG level
FBG level was significantly increased after the induction of diabetes. Treatment with melatonin and ALA significantly decreased the FBG level when compared to the diabetic untreated group (DG). Yet FBG level in ALA-treated group was significantly lower than that treated with melatonin (Table 2 ).
Effect of melatonin and ALA in non-diabetic rats
Results showed that the melatonin and ALA have no influence on AMPK activity, oxidative status, lipid profile and FBG levels in the normal nondiabetic rats. Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
